Applicant, as named in the Orange Book

Owp Pharms

Next listed expiry: Subvenite on 29 May 2040. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Subvenite lamotrigine	lamotrigine	218879	29 May 2040	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.